Nicotine Patches to Treat Long Covid

16 hours ago

The hypothesis that nicotine might treat Long COVID arose from early observations suggesting smokers were underrepresented in COVID hospitalizations, leading to speculation that nicotine could bind to receptors and block the virus.
Research into Long COVID is challenging due to its complexity and variability, with symptoms overlapping with conditions like ME/CFS and involving multiple bodily systems.
The evidence supporting nicotine's effectiveness for Long COVID is inconclusive and flawed, including contradictory lab results and problematic early data on smokers.
Nicotine patches are considered safer than other nicotine products for non-smokers due to slow, continuous release, but risks of addiction and long-term safety remain uncertain.
Online communities like The Nicotine Patch Test on Facebook offer protocols for using nicotine patches, despite mixed anecdotal reports and lack of rigorous scientific validation.
Long COVID treatment options remain limited, with pacing recommended, and ongoing research includes antivirals, probiotics, and new medications like tirzepatide.
Prevention of Long COVID through masking, air filtration, and vaccination remains crucial, despite public disregard.
Caution is advised due to potential misinformation and pseudoscientific endorsements from some proponents, including those with ties to the tobacco industry or alternative medicine practices.

Hasty Briefsbeta